Biolidics launches IPO to raise S$6.1m
Add BT as a preferred source
Singapore
MEDICAL technology company Biolidics on Tuesday launched an initial public offering (IPO) of 27.5 million new shares at S$0.28 each. The placement is in conjunction with its proposed listing on the Catalist board on Dec 19.
The shares will be placed out to retail and institutional investors in Singapore, and represent 11.34 per cent of the company's enlarged share capital. Upon completion of the IPO, Biolidics' market capitalisation is expected to be S$67.9 million.
TRENDING NOW
Xi Jinping has just rewritten the rules of US-China rivalry
‘Whole deck of cards just toppled’: FoodXervices’ Nichol Ng on how a 92-year-old family business unravelled – and what’s next
In the EV race, Japan’s most dangerous rival could be closer to home than China
Wilmar, Musim Mas among palm-oil firms in Indonesia under probe for suspected export under-invoicing
